Joyani Das, PhD, earned her doctoral degree in pharmacology from the Birla Institute of Technology in Mesra, India, and brings over six years of experience in medical research, education, and health communication. She works as a medical writer, creating evidence-based health content for a broad audience. Prior to this, she worked as a health writer at MomJunction, specializing in health and wellness topics related to women and children. She also served as an associate professor, contributing to academic research and mentoring students in pharmacological sciences. Her areas of expertise include medical writing and drug information.
Recent WebMD content from Joyani Das, PhD
- FDA Approves Palsonify: First Once-Daily Pill for Acromegaly in Adults
- Inluriyo: FDA Approves New Once-Daily Pill for ESR1-Mutated Advanced Breast Cancer in Patients Previously on Hormone Therapy
- Tremfya: First Fully Under-the-Skin IL-23 Inhibitor Shot Approved for Ulcerative Colitis and Crohn’s Disease
- Forzinity: New Once-Daily Shot Gets Accelerated FDA Nod for Boosting Muscle Strength in Barth Syndrome
- Keytruda Qlex: FDA Approves New Subcutaneous Immune Therapy Shot for Treating a Wide Range of Advanced Cancers
- Opzelura: FDA Expands Use of Steroid-Free Skin Cream for Young Children With Eczema
- FDA Approves Enbumyst: First and Only Nasal Spray Diuretic for Edema From Heart, Liver, and Kidney Diseases
- Vyjuvek Label Update: FDA Removes Lower Age Limit
- Ocaliva Pulled From U.S. Market for Liver Disease
- Inlexzo: A New Bladder Cancer Treatment
- FDA Expands Approved Use of Vonvendi
- FDA Approves At-Home Once-Weekly Leqembi Injection as Maintenance Therapy for Early Alzheimer's Disease
- Wayrilz: A New Twice-Daily Pill for Chronic Immune Thrombocytopenia Unresponsive to Other Therapies
- FDA Expands Repatha Approval
- Dawnzera: First RNA-Targeted Therapy to Prevent Hereditary Angioedema Attacks
- FDA Approves Wegovy as First Once-Weekly Injection for Obesity-Linked Liver Disease
- FDA Approves New Non-Opioid, Once-Daily Bedtime Tablet for Fibromyalgia Pain and Sleep Disturbance
- Brinsupri: First Once-Daily Tablet for Non-Cystic Fibrosis Bronchiectasis
- Hernexeos (Zongertinib) Approved as the First Oral Targeted Treatment for HER2-Mutant Advanced Lung Cancer
- Ajovy Approved as a First-of-Its-Kind Shot for Preventing Migraine in Children and Teens
- Leqvio: New Injectable Option for Lowering Bad Cholesterol Without Statins
- Vizz: New Daily Eye Drop to Improve Age-Related Blurry Near Vision
- Alhemo: A New Daily Injection to Help Prevent Bleeding in Hemophilia A and B
- Empaveli: A New Treatment Option for Rare Immune-Related Kidney Diseases
- New Oral Treatment for Adults and Children With Phenylketonuria: Sephience
- New Oral Option for Children With Low Platelet Counts: Doptelet
- FDA OKs New Steroid-Free Skin Cream for Hand Eczema
- FDA OKs Moderna’s COVID Shot for Kids, With Limits
- FDA Approves First Oral Treatment for Rare Swelling Disorder
- FDA OKs First-of-Its-Kind Lung Cancer Pill